Activation-Induced Cell Death and T Helper Subset Differentiation

  • Yufang Shi
  • Satish Devadas
  • Xiaoren Zhang
  • Liying Zhang
  • Achsah Keegan
  • Kristy Greeneltch
  • Jennifer Solomon
  • Zengrong Yuan
  • Erwei Sun
  • Catherine Liu
  • Jyoti Das
  • Megha Thayyil Satish
  • Lixin Wei
  • Jian-Nian Zhou
  • Arthur I. Roberts
Chapter

Abstract

Activation-induced cell death (AICD) has been demonstrated to occur in T cell hybridomas, immature thymocytes, and activated mature T cells. However, the molecular mechanisms and the physiological role of AICD in the differentiation of T helper cell subpopulations remain elusive. We have recently shown that activation-induced cell death in Thl and Th2 cells is executed via distinct mechanisms. Our results suggest that cytokine signals initiate the differentiation program, but it is the selective action of death effectors that determines the endpoint balance of differentiating T helper subsets. Activation-induced expression of TNF-related apoptosis-inducing ligand (TRAIL) is observed exclusively in Th2 clones and primary T helper cells differentiated under Th2 conditions, while the expression of CD95L (FasL) is mainly in Thl cells. Furthermore, Th2 cells are more resistant to either TRAIL- or CD95L-induced apoptosis than are Thl cells. Both Thl and Th2 cells can induce apoptosis in labeled Thl but not Th2 cells, and caspase inhibitor z-VAD inhibits AICD in Thl but not Th2 cells, implicating different mechanisms of AICD in these subpopulations. Blocking TRAIL CD95L significantly enhances IFN-g production in vitro. Likewise, young CD95-defective transgenic (MRL/MpJlpr/lpr) mice show a greater Thl response to ovalbumin immunization compared to control mice. Therefore, apoptosis mediated by CD95L and TRAIL is critical in determining the fate of differentiating T helper cells.

Keywords

Immature Thymocyte Helper Subset Autoreactive Thymocyte Ovalbumin Immunization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abbas, A. K., Murphy, K. M., and Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787–93.PubMedCrossRefGoogle Scholar
  2. Accornero, P., Radrizzani, M., Delia, D., Gerosa, F., Kurrle, R., and Colombo, M. P. (1997). Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T helper phenotypes: role of CD95/CD95L interactions. Blood 89, 558–69.PubMedGoogle Scholar
  3. Ashwell, J. D., Lu, F. W.. and Vacchio, M. S. (2000). Glucocorticoids in T cell development and function*. Annu Rev Immunol 18, 309–45.PubMedCrossRefGoogle Scholar
  4. Baumann, S., Krueger, A., Kirchhoff, S., and Krammer, P. H. (2002). Regulation of T cell apoptosis during the immune response. Curr Mol Med 2, 257–72.PubMedCrossRefGoogle Scholar
  5. Bensussan, A., Leca, G., Corvaia, N.. and Boumsell. L. (1990). Selective induction of autocytotoxic activity through the CD3 molecule. Eur J Immunol 20, 2615–9.PubMedCrossRefGoogle Scholar
  6. Boehme, S. A., and Lenardo, M. J. (1993a). Ligand-induced apoptosis of mature T lymphocytes (propriocidal regulation) occurs at distinct stages of the cell cycle. Leukemia 7 Suppl 2, S45–9.Google Scholar
  7. Boehme, S. A., and Lenardo, M. J. (1993b). Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23, 1552–60.PubMedCrossRefGoogle Scholar
  8. Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J. M., and Strasser. A. (2002). BH3-only Bel-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922–6.PubMedCrossRefGoogle Scholar
  9. Breitmeyer, J. B., Oppenheim, S. O., Daley, J. F., Levine, H. B., and Schlossman, S. F. (1987). Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol 138, 726–31.PubMedGoogle Scholar
  10. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., and et al. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441–4.PubMedCrossRefGoogle Scholar
  11. Chan, K. F., Siegel, M. R., and Lenardo, J. M. (2000). Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13, 419–22.PubMedCrossRefGoogle Scholar
  12. Constant, S. L., and Bottomly, K. (1997). Induction of Thl and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15, 297–322.PubMedCrossRefGoogle Scholar
  13. Donjerkovic, D., and Scott, D. W. (2000). Activation-induced cell death in B lymphocytes. Cell Res 10, 179–92.PubMedCrossRefGoogle Scholar
  14. Duke, R. C., Ojcius, D. M., and Young, J. D. (1996). Cell suicide in health and disease. Sci Am 275, 80–7. Ettinger, R., Panka, D. J.. Wang, J. K., Stanger, B. Z., Ju, S. T., and Marshak-Rothstein, A. (1995). Fasligand mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen. J Immunol 154, 4302–8.Google Scholar
  15. Farrar, J. D., Ouyang, W., Lohning, M., Assenmacher, M., Radbruch, A., Kanagawa, O., and Murphy, K. M. (2001). An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J Exp Med 193, 643–50.PubMedCrossRefGoogle Scholar
  16. Green, D. R., Bissonnette, R. P., Glynn, J. M., and Shi, Y. (1992). Activation-induced apoptosis in lymphoid systems. Semin Immunol 4, 379–88.PubMedGoogle Scholar
  17. Green, D. R., and Scott, D. W. (1994). Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6, 476–87.PubMedCrossRefGoogle Scholar
  18. Habibovic, S., Hrgovic, Z., Bukvic, I., and Hrgovic, I. (2000). [Molecular mechanisms in apoptosis]. MedArh 54, 33–40.Google Scholar
  19. Hamad, A. R., and Schneck, J. P. (2001). Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol 20, 535–46.PubMedCrossRefGoogle Scholar
  20. Henkart, P. A., Williams, M. S., Zacharchuk, C. M., and Sarin, A. (1997). Do CTL kill target cells by inducing apoptosis? Semin Immunol 9, 135–44.PubMedCrossRefGoogle Scholar
  21. Janssen, O., Sanzenbacher, R., and Kabelitz, D. (2000). Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res 301, 85–99.PubMedCrossRefGoogle Scholar
  22. Janssen, O., Wesselborg, S., and Kabelitz, D. (1992). Immunosuppression by OKT3-induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 53, 233–4.PubMedGoogle Scholar
  23. Jenkinson, E. J., Kingston, R., Smith, C. A., Williams, G. T., and Owen, J. J. (1989). Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 19, 2175–7.PubMedCrossRefGoogle Scholar
  24. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444–8.PubMedCrossRefGoogle Scholar
  25. Kabelitz, D., and Janssen, O. (1997). Antigen-induced death of T-Lymphocytes. Front Biosci 2, d61–77. Kamogawa, Y., Minasi, L. A., Carding, S. R., Bottomly, K., and Flavell, R. A. (1993). The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75, 985–95.Google Scholar
  26. Kim, J., Woods, A., Becker-Dunn, E., and Bottomly, K. (1985). Distinct functional phenotypes of cloned Iarestricted helper T cells. J Exp Med 162, 188–201.PubMedCrossRefGoogle Scholar
  27. Kishimoto, H., Surh, C. D., and Sprent, J. (1998). A role for Fas in negative selection of thymocytes in vivo. J Exp Med 187, 1427–38.PubMedCrossRefGoogle Scholar
  28. Lamhamedi-Cherradi, S. E., Zheng, S. J., Maguschak, K. A., Peschon, J., and Chen, Y. H. (2003). Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice. Nat Immunol 10, 10.Google Scholar
  29. Lenardo, M. J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858–61.PubMedCrossRefGoogle Scholar
  30. Levine, B. L., Bernstein, W. B., Connors, M., Craighead, N., Lindsten, T., Thompson, C. B., and June, C. H. (1997). Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. Jlmmunol 159, 5921–30.Google Scholar
  31. Martinez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, K. J., Chuntharapai, A., Pineiro, A., Naval, J., and Anel, A. (1998). Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 28, 2714–25.PubMedCrossRefGoogle Scholar
  32. McConkey, D. J., Jondal, M., and Orrenius, S. (1992). Cellular signaling in thymocyte apoptosis. Semin Immunol 4, 371–7.PubMedGoogle Scholar
  33. Mercep, M., Bluestone, J. A., Noguchi, R D., and Ashwell, J. D. (1988). Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 140, 324–35.PubMedGoogle Scholar
  34. Miner, K. T., and Croft, M. (1998). Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma. J Immunol 160, 5280–7.PubMedGoogle Scholar
  35. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Jlmmunol 136, 2348–57.Google Scholar
  36. Mountz, J. D., Zhou, T., Su, X., Cheng, J., Pierson, M., Bluethmann, H., and Edwards, C. K., 3rd (1996). Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Inst Mitt, 200–19.Google Scholar
  37. Murphy, K. M. (1998). T lymphocyte differentiation in the periphery. Curr Opin Immunol 10, 226–32.PubMedCrossRefGoogle Scholar
  38. Murphy, K. M., Heimberger, A. B., and Loh, D. Y. (1990). Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRIo thymocytes in vivo. Science 250, 1720–3.PubMedCrossRefGoogle Scholar
  39. Naramura, M., Kole, H. K., Hu, R. J., and Gu, H. (1998). Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci U S A 95, 15547–52.PubMedCrossRefGoogle Scholar
  40. Nau, G. J., Moldwin, R. L., Lancki, D. W., Kim, D. K., and Fitch, F. W. (1987). Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol 139, 114–22.PubMedGoogle Scholar
  41. Oberg, H. H., Lengl-Janssen, B., Kabelitz, D., and Janssen, O. (1997). Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell Immunol 181, 93–100.PubMedCrossRefGoogle Scholar
  42. Orchansky, P. L., and Teh, H. S. (1994). Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits. J Immunol 153, 615–22.PubMedGoogle Scholar
  43. Paul, W. E., and Seder, R. A. (1994). Lymphocyte responses and cytokines. Cell 76, 241–51.PubMedCrossRefGoogle Scholar
  44. Pawelec, G., Sansom, D., Rehbein, A., Adibzadeh, M., and Beckman, I. (1996). Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol 31, 655–68.PubMedCrossRefGoogle Scholar
  45. Ramsdell, F., Seaman, M. S., Miller, R. E., Picha, K. S., Kennedy, M. K., and Lynch, D. H. (1994). Differential ability of Th 1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6, 1545–53.PubMedCrossRefGoogle Scholar
  46. Reed, J. C., and Tomaselli, K. J. (2000). Drug discovery opportunities from apoptosis research. Curr Opin Biotech-nol 11, 586–92.CrossRefGoogle Scholar
  47. Riviere, I., Sunshine, M. J., and Littman, D. R. (1998). Regulation of IL-4 expression by activation of individual alleles. Immunity 9, 217–28.PubMedCrossRefGoogle Scholar
  48. Rothstein, T. L., Wang, J. K., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T., and MarshakRothstein, A. (1995). Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163–5.PubMedCrossRefGoogle Scholar
  49. Russell, J. H. (1995). Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7, 382–8.PubMedCrossRefGoogle Scholar
  50. Schmitz, I., Kirchhoff, S., and Krammer, P. H. (2000). Regulation of death receptor-mediated apoptosis pathways. Int.1 Biochem Cell Biol 32, 1123–36.CrossRefGoogle Scholar
  51. Scott, D. W. (1993). Analysis of B cell tolerance in vitro. Adv Immunol 54, 393–425.PubMedCrossRefGoogle Scholar
  52. Scott, D. W., Grdina, T., and Shi, Y. (1996). T cells commit suicide, but B cells are murdered! J Immunol 156, 2352–6.PubMedGoogle Scholar
  53. Secchiero, P., Gonelli, A., Celeghini, C., Mirandola, P., Guidotti, L., Visani, G., Capitani, S., and Zauli, G. (2001). Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Blood 98, 2220–8.PubMedCrossRefGoogle Scholar
  54. Sharma, K., Wang, R. X., Zhang, L. Y., Yin, D. L., Luo, X. Y., Solomon, J. C., Jiang, R. F., Markos, K., Davidson, W., Scott, D. W., and Shi, Y. F. (2000). Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 88, 333–47.PubMedCrossRefGoogle Scholar
  55. Shi, Y. F., Bissonnette, R. P., Parfrey, N., Szalay, M., Kubo, R. T., and Green, D. R. (1991). In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 146, 3340–6.PubMedGoogle Scholar
  56. Shi, Y. F., Sahai, B. M., and Green, D. R. (1989). Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339, 625–6.PubMedCrossRefGoogle Scholar
  57. Shi, Y. F., Szalay, M. G., Paskar, L., Sahai, B. M., Boyer, M., Singh, B., and Green, D. R. (1990). Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol 144, 3326–33.PubMedGoogle Scholar
  58. Simon, A. K., Williams, O., Mongkolsapaya, J., Jin, B., Xu, X. N., Walczak, H., and Screaton, G. R. (2001). Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci U S A 98, 5158–63.Google Scholar
  59. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., and Owen, J. J. (1989). Antibodies to CD3/Tcell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181–4.PubMedCrossRefGoogle Scholar
  60. Sprent, J., and Tough, D. F. (1994). Lymphocyte life-span and memory. Science 265, 1395–400.PubMedCrossRefGoogle Scholar
  61. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K., and Nagata, S. (1995). Expression of the Fas ligand in cells of T cell lineage. J Immunol 154, 3806–13.PubMedGoogle Scholar
  62. Sytwu, H. K., Liblau, R. S., and McDevitt, H. O. (1996). The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5, 17–30.PubMedCrossRefGoogle Scholar
  63. Tamada, K., Ni, J., Zhu, G., Fiscella, M., Teng, B., van Deursen, J. M., and Chen, L. (2002). Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT. J Immunol 168, 4832–5.PubMedGoogle Scholar
  64. Tough, D. F., and Sprent, J. (1995). Life span of naive and memory T cells. Stem Cells 13, 242–9.PubMedCrossRefGoogle Scholar
  65. Trapani, J. A., Sutton, V. R., and Smyth, M. J. (1999). CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today 20, 351–6.PubMedCrossRefGoogle Scholar
  66. Van Parijs, L., and Abbas, A. K. (1996). Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 8, 355–61.PubMedCrossRefGoogle Scholar
  67. Van Parijs, L., Ibraghimov, A., and Abbas, A. K. (1996). The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4, 321–8.PubMedCrossRefGoogle Scholar
  68. Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M., and Salgame, P. (1997). Differential ability of TGoogle Scholar
  69. cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A 94, 5778–83.Google Scholar
  70. Wang, E. C., Them, A., Denzel, A., Kitson, J., Farrow, S. N., and Owen, M. J. (2001). DR3 regulates negativeGoogle Scholar
  71. selection during thymocyte development. Mol Cell Biol 21, 3451–61.Google Scholar
  72. Wang, R., Brunner, T., Zhang, L., and Shi, Y. (1998). Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression. Oncogene 17, 1503–8.PubMedCrossRefGoogle Scholar
  73. Wang, R., Ciardelli, T. L., and Russell, J. H. (1997). Partial signaling by cytokines: cytokine regulation of cellGoogle Scholar
  74. cycle and Fas-dependent, activation-induced death in CD4+ subsets. Cell Immunol 182, 152–60.Google Scholar
  75. Watanabe, N., Arase, H., Kurasawa, K., Iwamoto, I., Kayagaki, N., Yagita, H., Okumura, K., Miyatake, S., and Saito, T. (1997). Thl and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur J Immunol 27, 1858–64.PubMedCrossRefGoogle Scholar
  76. Webb, S. R., Li, J. H., MacNeil, I., Marrack, P., Sprent, J., and Wilson, D. B. (1985). T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes. J Exp Med 161, 269–74.Google Scholar
  77. Zhang, X. R., L. Y. Zhang, L. Li, L. H. Glimcher, A. D. Keegan, and Y. F. Shi (2003). Reciprocal Expression of TRAIL and CD95L in Thl and Th2 Cells: Role of Apoptosis in T Helper Subset Differentiation. Cell Death and Differentiation In Press.Google Scholar
  78. Zhou, T., Edwards, C. K., 3rd, and Mountz, J. D. (1995). Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 182, 129–37.PubMedCrossRefGoogle Scholar
  79. Zhou, T. Mountz, J. D. and Kimberly, R. P. (2002). Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 26 323–36.Google Scholar
  80. Zimmermann, K. C., Bonzon, C., and Green, D. R. (2001). The machinery of programmed cell death. Pharmacol Ther 92, 57–70.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Yufang Shi
  • Satish Devadas
  • Xiaoren Zhang
  • Liying Zhang
  • Achsah Keegan
  • Kristy Greeneltch
  • Jennifer Solomon
  • Zengrong Yuan
  • Erwei Sun
  • Catherine Liu
  • Jyoti Das
  • Megha Thayyil Satish
  • Lixin Wei
  • Jian-Nian Zhou
  • Arthur I. Roberts
    • 1
  1. 1.Department of Molecular Genetics, Microbiology and ImmunologyUniversity of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical SchoolPiscatawayUSA

Personalised recommendations